When facility births were simulated to use quality oxytocin alone, annual severe PPH cases decreased by 2,162 (5%) cases, cases needing blood transfusion decreased by 7,798 (24%), maternal deaths decreased by 47 (5%), YLL decreased by 1,104 (5%), and long-term productivity loss decreased by $2.6 million (~GH₵15.1 million; 5%). The gene discussed is OXT; the disease is pulmonary arterial hypertension.